Anti-inflammatory effects of anti-platelet treatment in atherosclerosis

Keyphrases

• Antiplatelet Therapy 100%
• Anti-inflammatory Effect 100%
• Antithrombotic Therapy 50%
• Acute Coronary Syndrome 50%
• Clinical Setting 50%
• Atherosclerotic Plaque 50%
• Aspirin 50%
• T Cells 50%
• Mechanism of Action 50%
• Inflammatory Diseases 50%
• Cell-to-cell 50%
• Response to Treatment 50%
• Plaque 50%
• Platelets 50%
• Bleeding Risk 50%
• Platelet Function 50%
• Platelet Inhibition 50%
• Inflammatory Mediators 50%
• Cell Infiltration 50%
• Endothelial Dysfunction 50%
• Macrophage Cells 50%
• Inflammatory State 50%
• Plaque Progression 50%
• Mast Cells 50%
• Anti-inflammatory Properties 50%
• Inflammatory Markers 50%
• Platelet Activation 50%
• Risk-benefit 50%
• Variable Response 50%
• Antiplatelet Drugs 50%
• Platelet-leukocyte Interaction 50%
• GP IIb/IIIa Inhibitors 50%

Medicine and Dentistry

• Antiplatelet 100%
• Atherosclerosis 100%
• Platelet 100%
• Antiinflammatory Activity 100%
• Leukocyte 50%
• Bleeding 50%
• Inflammatory Disorder 50%
• Macrophage 50%
• Decision Making 50%
• Antithrombotic 50%
• Thrombocyte Function 50%
• Antiplatelet Drug 50%
• Acetylsalicylic Acid 50%
• Thrombocyte Aggregation 50%
• T Cell 50%
• Cellular Infiltration 50%
• Inflammatory Mediator 50%
• Mast Cell 50%
• Thrombocyte Activation 50%
• Endothelial Dysfunction 50%
• Acute Coronary Syndrome 50%
• Atherosclerotic Plaque 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiplatelet 100%
• Atherosclerosis 100%
• Antiinflammatory Activity 100%
• Anticoagulant Agent 50%
• Acute Coronary Syndrome 50%
• Bleeding 50%
• Acetylsalicylic Acid 50%
• Inflammatory Disease 50%
• Endothelial Dysfunction 50%
• Antithrombocytic Agent 50%
• Atherosclerotic Plaque 50%